XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning Balance at Dec. 31, 2021 $ 459,638 $ 5 $ 689,275 $ (228,982) $ (660)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021   51,536,181      
Exercise of stock options 449   449    
Exercise of stock options, Shares   142,270      
Vesting restricted stock, Shares   14,215      
Stock-based compensation expense 7,873   7,873    
Unrealized gain (loss) on marketable securities (2,556)       (2,556)
Net Loss (36,684)     (36,684)  
Ending Balance at Mar. 31, 2022 428,720 $ 5 697,597 (265,666) (3,216)
Shares, Outstanding, Ending Balance at Mar. 31, 2022   51,692,666      
Beginning Balance at Dec. 31, 2022 490,151 $ 6 878,884 (383,790) (4,949)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022   55,039,380      
Exercise of stock options 1,486   1,486    
Exercise of stock options, Shares   208,705      
Vesting restricted stock, Shares   28,141      
Stock-based compensation expense 9,385   9,385    
Unrealized gain (loss) on marketable securities 1,911       1,911
Net Loss (40,928)     (40,928)  
Ending Balance at Mar. 31, 2023 $ 462,005 $ 6 $ 889,755 $ (424,718) $ (3,038)
Shares, Outstanding, Ending Balance at Mar. 31, 2023   55,276,226